Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study.
Maxim GrymonprezStephane SteurbautAndreas CapiauDelphine VauterinFrauke Van VaerenberghEls MehuysKoen BousseryTine L De BackerLies LahoussePublished in: Cardiovascular drugs and therapy (2023)
Poor adherence to NOACs is associated with increased risks of thromboembolism and all-cause mortality. The minimal adherence threshold should be ≥ 90%, preferably even ≥ 95%.